Connect with us

Technology

DSM-Firmenich AG sold all of its stake in Robertet S.A.

Published

on

KAISERAUGST, Switzerland and MAASTRICHT, Netherlands, Nov. 21, 2024 /PRNewswire/ — DSM-Firmenich AG, through its affiliate Firmenich International S.A. (“dsm-firmenich”), announces that it has successfully sold 24,408 Robertet S.A. (“Robertet”) ordinary shares, representing c. 1% of Robertet share capital, through a bilateral sale to a long-term, non-institutional investor that will be subject to a 60-day lockup undertaking.

Following the above transaction, dsm-firmenich no longer retains any ordinary shares in Robertet.

For more information, please contact:

dsm-firmenich investor relations enquiries:
Email: investors@dsm-firmenich.com 

dsm-firmenich media enquiries:
Email: media@dsm-firmenich.com     

About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. www.dsm-firmenich.com

Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance, transaction progress and positions to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.

Logo – https://mma.prnewswire.com/media/2071772/5039811/dsm_firmenich_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/dsm-firmenich-ag-sold-all-of-its-stake-in-robertet-sa-302311997.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Connecticut-Based Operational Solutions Software Provider Lands a Technology Contract for the Texas Department of Information Resources

Published

on

By

Veoci, a national leader in digitizing and optimizing government procedures, brings its substantial expertise to the Lone Star State.

NEW HAVEN, Conn., Nov. 21, 2024 /PRNewswire-PRWeb/ — This week, Connecticut-based company Veoci announced that it has been awarded a contract by the Texas Department of Information Resources (DIR) to offer technology to state and local governments through DIR’s Cooperative Contracts Program.

Adding our tools to DIR’s arsenal isn’t just a win for Veoci, but for government workers across Texas, one of America’s busiest states.

In receiving DIR contract #DIR-CPO-5533, Veoci, will make its services available to Texas’ state and local government bodies. As a result, community leaders there will have access to a no-code, cloud-based software platform empowering them to streamline emergency response, gain continuity in operations planning, manage critical events across multiple locations with agility, centralize inspection and incident reporting, and more.

“Adding our tools to DIR’s arsenal isn’t just a win for Veoci, but for government workers across Texas, one of America’s busiest states,” said Chris Ford, VP of Sales & Partnerships at Veoci. “Nationwide, we are a proven provider for cities, counties, state agencies, school systems, and healthcare institutions thanks to our always-on, customizable tools. Thanks to our DIR contract, even more organizations across the Lone Star State can easily access the operational benefits we provide.

With our ability to stand up centralized reporting and databases, improve situational awareness through real-time communications, and refine operations through after-action reporting and evaluations, we are one of the best tools DIR customers can adopt to enhance their emergency response capabilities.”

To learn more about Veoci’s partnership with DIR and how its operational software can improve your community, contact Mark Demski or visit www.veoci.com.

About Veoci

Veoci is a no-code, cloud platform for Crisis, Incident, and Emergency Management, Business Continuity and Resilience, Continuity of Operations Planning, Team Collaboration, and Daily Operations, designed to meet the decision-making and communication requirements of multiple teams at many locations. With stringent security, highest availability, and quickly scalable performance, Veoci is designed for institutions and organizations of every size and complexity.

Media Contact

Mark Demski, Veoci, 1 475-244-9629, mark.demski@veoci.com, www.veoci.com

View original content:https://www.prweb.com/releases/connecticut-based-operational-solutions-software-provider-lands-a-technology-contract-for-the-texas-department-of-information-resources-302313140.html

SOURCE Veoci

Continue Reading

Technology

Draper to Develop an Advanced, Multi-Organ, Microphysiological System Architecture

Published

on

By

Draper’s ETHOS program will create a scalable microphysiological system (MPS) architecture consisting of interacting advanced immune-competent micro-organ (liver, lung, kidney) models, which will be used to predict disease/injury response in the body and medical countermeasure response.

CAMBRIDGE, Mass., Nov. 21, 2024 /PRNewswire-PRWeb/ — The field of microphysiological systems has continued to evolve during the past 20 years, doing so in response to the tremendous challenges facing pharmaceutical development and national biodefense initiatives. This includes the high cost, lack of availability and limited human clinical relevance of animal models.

Draper looks forward to advancing these MPS-based capabilities for DTRA and their U.S. government partners in order to protect the warfighter against high-priority threats and accelerate our response to future threats.

Draper is responding to these national security challenges and announces the $34.1 million award of the Evaluation of Treatments using High-throughput Multi-Organ Systems (ETHOS) program.

The Defense Threat Reduction Agency (DTRA), Joint Science and Technology Office (JSTO), Vaccines/Therapeutics Division (CBM) is the government sponsor for this program.

DTRA’s Research and Development Directorate provides science, technology and capability development investments that maintain the U.S. military’s technological superiority in countering weapons of mass destruction and emerging threats, mitigate the risks of technical surprise and respond to the warfighters’ urgent technical requirements. (Sources: https://www.dtra.mil/About/Mission/Research-and-Development/, https://www.dtra.mil/Portals/125/Documents/CB/DTRA-JSTO_E-book_PDF.pdf)

The overall objectives of the ETHOS program are to create a scalable microphysiological system architecture that consists of interacting immune-competent micro-organ (lung, liver, kidney) models to predict the body’s disease response and test medical countermeasure (MCM) responses.

Draper’s advanced models will include parenchymal, vascular and innate immune components to capture a broad range of biological responses. The technical approach will be to create a new multi-organ platform to understand disease progression of high-priority BSL-3 agents and determine the safety and efficacy of MCM treatments.

“Draper looks forward to advancing these MPS-based capabilities for DTRA and their U.S. government partners in order to protect the warfighter against high-priority threats and accelerate our response to future threats,” said Roger Odegard, the Draper ETHOS program manager.

DTRA has recognized that significant research and development in the MPS technology area will improve the state-of-the-art capability to analyze the pathogenesis of disease and injuries that result from exposure to high-priority pathogens and toxins.

Additionally, next-generation MPS technologies and systems will be critical in the evaluation of efficacious and safe medical countermeasures (MCM) to combat these threats and allow the military to be equipped to meet its mission. This will include investigating and characterizing the mechanisms of infection/inflammation/tissue damage across relevant population demographics (e.g., military age, sex, co-morbidities and previous exposure) and under varying conditions (e.g., exposure levels, drug doses and time scales) for a variety of threats. These technology innovations represent a state-of-the-art tool for pharmaceutical solutions that has the potential to significantly accelerate the process of evaluating effective and safe MCMs for emerging, naturally or engineered threats.

This project has been funded in whole or in part with federal funds from the Department of Defense (DoD); The Defense Threat Reduction Agency (DTRA); Joint Science and Technology Office (JSTO), Vaccines/Therapeutics Division (CBM) through the Medical CBRN Defense Consortium (MCDC) Agreement No. MCDC2201-003.

Draper

Draper is an independent, nonprofit research and development company headquartered in Cambridge, Mass. with campuses located across the United States. The 2,300 employees of Draper tackle important national challenges with a promise of delivering successful and usable solutions. From military defense and space exploration to biotechnology, lives often depend on the solutions we provide. Our multidisciplinary teams of engineers and scientists work in a collaborative environment that inspires the cross fertilization of ideas necessary for true innovation. For more information about Draper, visit www.draper.com.

Media Contact

Scott Deitz, Draper, 1 336-908-7759, scott@sevenletter.com, Draper.com

View original content to download multimedia:https://www.prweb.com/releases/draper-to-develop-an-advanced-multi-organ-microphysiological-system-architecture-302313153.html

SOURCE Draper

Continue Reading

Technology

OhWaiter and Stellar Menus Announce a Strategic Merger to Form MilesCX, Revolutionizing Hospitality with AI-Driven Solutions

Published

on

By

OhWaiter and Stellar Menus have joined forces to create MilesCX, a groundbreaking company redefining hospitality with AI-driven solutions that enhance guest experiences, optimize operations, and boost revenue. With cutting-edge tools like AI-powered guest communications and dynamic menus, MilesCX is empowering prestigious properties to deliver seamless, personalized service and stay ahead in a competitive market.

LOS ANGELES, Nov. 21, 2024 /PRNewswire-PRWeb/ — OhWaiter and Stellar Menus, leading innovators in hospitality technology, have merged to form Miles Customer Experience (MilesCX), a company dedicated to transforming the hospitality industry through AI-driven solutions. By uniting Stellar Menus’ product expertise with OhWaiter’s strategic growth initiatives, MilesCX is poised to meet the evolving needs of hotels, private clubs, and golf courses.

“This merger unites innovation and expertise to deliver AI-driven solutions that transform guest experiences and drive growth,” said Steven Latasa-Nicks, CEO of MilesCX. “In today’s labor market, we help businesses exceed guest expectations, boost efficiency, and ease the burden on staff.”

MilesCX will deliver intelligent guest communications, business intelligence tools, dynamic menus, and AI-powered upselling, enabling hospitality leaders to enhance guest experiences, increase sales, and streamline operations.

“This merger allows us to combine our strengths and deliver a truly unique product that will redefine guest experiences in the hospitality industry,” said Steven Latasa-Nicks, CEO of MilesCX and Stellar Menus. “Our AI-driven platform will empower hotels and clubs to offer seamless, personalized service while optimizing their operations and reducing costs.”

Notable early adopters of the MilesCX platform include prestigious properties such as the Los Angeles Athletic Club (managed by Crescent Hotels & Resorts), The Chamberlain (operated by Springboard Hospitality), and Hotel Indigo (under StepStone Hospitality). These clients are leveraging AI-driven guest communications and personalized service to enhance satisfaction and streamline operations.

“With this merger, we’re not just expanding our product portfolio—we’re expanding the possibilities for our clients,” said Jonathan Chu, CEO of OhWaiter. “Our AI-powered solutions, combined with dynamic customer engagement tools, will help hospitality businesses increase revenue, reduce the cost of service delivery, and stay ahead of the competition.”

MilesCX will focus on proving market fit over the coming months, aiming to grow its client base and Annual Recurring Revenue (ARR). Leveraging the strengths of both companies, MilesCX is confident in its ability to capture new opportunities in the hospitality sector.

About MilesCX:

Miles Customer Experience (MilesCX) is a pioneering company at the forefront of AI-driven hospitality solutions. Formed through the merger of Stellar Menus and OhWaiter, MilesCX offers advanced tools that enhance guest communication, streamline operations, and boost sales through personalized, AI-powered recommendations. MilesCX is dedicated to empowering hospitality businesses, including hotels, clubs, and restaurants, to deliver exceptional service while optimizing efficiency and driving growth.

Media Contact

AJ Vernet, MilesCX, 1 213-898-2730, aj@milescx.com, https://milescx.com

LinkedIn

View original content:https://www.prweb.com/releases/ohwaiter-and-stellar-menus-announce-a-strategic-merger-to-form-milescx-revolutionizing-hospitality-with-ai-driven-solutions-302313129.html

SOURCE MilesCX

Continue Reading

Trending